Suppr超能文献

TP53 基因突变与口腔舌癌原位小鼠模型中侵袭性疾病特征相关。

Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.

机构信息

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Clin Cancer Res. 2011 Nov 1;17(21):6658-70. doi: 10.1158/1078-0432.CCR-11-0046. Epub 2011 Sep 8.

Abstract

PURPOSE

To characterize tumor growth and metastatic potential in head and neck squamous cell carcinoma (HNSCC) cell lines in an orthotopic murine model of oral tongue cancer and to correlate TP53 mutation status with these findings.

EXPERIMENTAL DESIGN

Cells from each of 48 HNSCC cell lines were orthotopically injected into the oral tongues of nude mice. Tumor volume, cervical lymph node metastasis, and mouse survival were recorded. Direct sequencing of the TP53 gene and Western blot analysis for the p53 protein after induction with 5-fluorouracil was conducted. Cell lines were categorized as either mutant TP53 or wild-type TP53, and lines with TP53 mutation were further categorized on the basis of type of mutation (disruptive or nondisruptive) and level of p53 protein expression. The behavior of tumors in these different groups was compared.

RESULTS

These 48 HNSCC cell lines showed a wide range of behavior from highly aggressive and metastatic to no tumor formation. Mice injected with cells harboring disruptive TP53 mutations had faster tumor growth, greater incidence of cervical lymph node metastasis, and shorter survival than mice injected with cells lacking these mutations.

CONCLUSIONS

HNSCC cell lines display a wide spectrum of behavior in an orthotopic model of oral cancer. Cell lines with disruptive TP53 mutations are more aggressive in this system, corroborating clinical reports that have linked these mutations to poor patient outcome.

摘要

目的

在口腔舌癌的原位啮齿动物模型中,描述头颈部鳞状细胞癌(HNSCC)细胞系的肿瘤生长和转移潜能,并将 TP53 突变状态与这些发现相关联。

实验设计

将来自 48 种 HNSCC 细胞系的细胞分别原位注射到裸鼠的口腔舌中。记录肿瘤体积、颈部淋巴结转移和小鼠存活情况。对 TP53 基因进行直接测序,并对 5-氟尿嘧啶诱导后的 p53 蛋白进行 Western blot 分析。根据 TP53 突变的类型(破坏性或非破坏性)和 p53 蛋白表达水平,将细胞系归类为突变型 TP53 或野生型 TP53。对携带 TP53 突变的细胞系进一步分类,根据突变类型(破坏性或非破坏性)和 p53 蛋白表达水平进行分类。比较这些不同组中肿瘤的行为。

结果

这 48 种 HNSCC 细胞系的行为范围从高度侵袭性和转移性到无肿瘤形成。与缺乏这些突变的细胞相比,注射携带破坏性 TP53 突变的细胞的小鼠具有更快的肿瘤生长、更高的颈部淋巴结转移发生率和更短的存活时间。

结论

HNSCC 细胞系在口腔癌的原位模型中表现出广泛的行为。在该系统中,具有破坏性 TP53 突变的细胞系更具侵袭性,这与将这些突变与患者预后不良相关的临床报告一致。

相似文献

1
Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
Clin Cancer Res. 2011 Nov 1;17(21):6658-70. doi: 10.1158/1078-0432.CCR-11-0046. Epub 2011 Sep 8.
2
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Clin Cancer Res. 2012 Jan 1;18(1):290-300. doi: 10.1158/1078-0432.CCR-11-2260. Epub 2011 Nov 16.
3
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
N Engl J Med. 2007 Dec 20;357(25):2552-61. doi: 10.1056/NEJMoa073770.
6
TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Laryngoscope. 2014 Jul;124(7):E267-73. doi: 10.1002/lary.24595. Epub 2014 Feb 20.
10
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
J Cell Biochem. 2016 Dec;117(12):2682-2692. doi: 10.1002/jcb.25592. Epub 2016 Jun 3.

引用本文的文献

1
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers.
Cell Mol Biol Lett. 2025 Jun 14;30(1):68. doi: 10.1186/s11658-025-00751-5.
2
CircTP53/USP10/p53 signaling Axis as a Novel Regulator of Progression and Prognosis of Head and Neck Squamous Cell Carcinoma.
Adv Sci (Weinh). 2025 Aug;12(30):e14961. doi: 10.1002/advs.202414961. Epub 2025 Jun 4.
5
Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell Cultures.
Laryngoscope. 2024 Jun;134(6):2748-2756. doi: 10.1002/lary.31236. Epub 2024 Jan 30.
6
Ethanol induces replication fork stalling and membrane stress in immortalized laryngeal cells.
iScience. 2023 Nov 23;26(12):108564. doi: 10.1016/j.isci.2023.108564. eCollection 2023 Dec 15.
8
Metal-Based Anticancer Complexes and p53: How Much Do We Know?
Cancers (Basel). 2023 May 19;15(10):2834. doi: 10.3390/cancers15102834.
9
Molecular risk factors for locoregional recurrence in resected non-small cell lung cancer.
Cancer Med. 2023 Jul;12(14):15026-15036. doi: 10.1002/cam4.6165. Epub 2023 May 29.

本文引用的文献

1
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
Clin Cancer Res. 2011 Dec 1;17(23):7248-64. doi: 10.1158/1078-0432.CCR-11-0690. Epub 2011 Aug 25.
2
Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
Clin Cancer Res. 2011 Jun 1;17(11):3733-41. doi: 10.1158/1078-0432.CCR-11-0183. Epub 2011 Apr 5.
3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
5
Cancer statistics, 2010.
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
6
Human papillomavirus and survival of patients with oropharyngeal cancer.
N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.
8
Xenograft models of head and neck cancers.
Head Neck Oncol. 2009 Aug 13;1:32. doi: 10.1186/1758-3284-1-32.
9
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma.
Br J Cancer. 2008 Nov 18;99(10):1684-94. doi: 10.1038/sj.bjc.6604735. Epub 2008 Oct 28.
10
Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination.
Cancer Biol Ther. 2008 May;7(5):699-708. doi: 10.4161/cbt.7.5.5712. Epub 2008 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验